Galvanis
Galvanis is a biotechnology company that develops preclinical ophthalmic drugs to improve epithelial closure.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJul 25, 2011 (15 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Pre Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
CR
Cody Rasmussen-Ivey Founder and CEOsource: galvanis.com
Companies like Galvanis
CCORE Biomedicine$21M Series A · Jul 2026
CClaris Bio$118M Series B+ · Jul 2026
JJishitongguangSeed · Sep 2026
EEeum BioSeed · Sep 2026
PParticellaGGoaTherapeutics$15.5M Seed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/galvanis (get a free API key).